NewsRx

Search our medical news database

AIDS Therapies

2 Against 1

Published in Gene Therapy Weekly, July 26th, 1999

An HIV-2-based gene therapy suppresses HIV-1.

University of Michigan researchers Catherine M. Browning, David M. Markovitz, and colleagues have been developing a gene therapy approach to the treatment of AIDS. This approach targets the Tat activation-response (TAR) element of the AIDS virus by causing cells to express TAR decoys. They soak up the HIV protein Tat like a sponge, leaving less of it to bind to actual TAR and thus slowing a process essential to rapid HIV replication.

Now Browning et al. show that the HIV-2 TAR (TAR-2) actually binds HIV-1 Tat more efficiently than HIV-1 TAR (TAR-1).

"We have directly proven that...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook